Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project
The WP3 hospitalized cohort in EuCARE is an observational multicentre study including collection of retrospective (historical) and prospective data from hospitalized COVID-19 patients followed at 12 clinics from 11 countries from 4 continents. In a subset of patients, peripheral blood, viral isolates and/or viral seque
| Condition(s) | COVID-19 |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The WP3 hospitalized cohort in EuCARE is an observational multicentre study including collection of retrospective (historical) and prospective data from hospitalized COVID-19 patients followed at 12 clinics from 11 countries from 4 continents. In a subset of patients, peripheral blood, viral isolates and/or viral sequences are collected for analysis in WP2 with regards to neutralising antibodies, cellular immunity and SARS-CoV-2 diagnostics. Data and results from analysis of biological material will be analysed by biostatistical methods and with artificial intelligence in WP5. This analysis will focus on the impact on clinical outcome of viral variants / viral sequences as well as the vaccines used and the vaccination schedules. |
| Who can participate | Inclusion Criteria: * Hospitalized adult (\>18 years) patients including patients in the emergency ward * Positive for SARS-CoV-2 by PCR any time from 14 days before admission date until hospital discharge. Both first and recurrent episodes of COVID-19 will be included. * Having a signed informed consent when required by ethical approval Exclusion Criteria: none |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Euresist Network GEIE |
| Locations | Düsseldorf, Germany; Milan, Lombardy, Italy; Rome, Italy; Nairobi, Kenya; Vilnius, Lithuania; Villahermosa, Mexico (+4 more sites) |
| Start date | 2022-02-23 |
| NCT ID | NCT05463380 |
| Official listing | https://clinicaltrials.gov/study/NCT05463380 |